Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2018, Article ID 1015408, 5 pages
https://doi.org/10.1155/2018/1015408
Case Report

Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis

1Department of Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI, USA
2Department of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA

Correspondence should be addressed to Nirmal Kaur; gro.shfh@1ruakn

Received 8 January 2018; Accepted 15 April 2018; Published 15 May 2018

Academic Editor: Warwick S. Selby

Copyright © 2018 Ravish Parekh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ravish Parekh, Ahmed Abdulhamid, Sheri Trudeau, and Nirmal Kaur, “Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis,” Case Reports in Gastrointestinal Medicine, vol. 2018, Article ID 1015408, 5 pages, 2018. https://doi.org/10.1155/2018/1015408.